Short description
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
Description
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
It is always working to improve the largest value inflection point in the drug development value chain, believing that speeding oncology medication innovation is the most effective method to provide help and hope to cancer patients around the world.
It is founded by Bing Yuan, Eric Slosberg, and Andy Fu.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
New York, New York, United States, North America
Founded on
January 1, 2021
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Blurry Noaccess, Noaccess, Noaccess, Blurry Noaccess, No Way, Noaccessforu, Noaccess, Noaccess, No Way, No Way, Noaccess, Noaccess, Noaccess
Sign in for full access
Founders
Andy Fu, Bing Yuan, Eric Slosberg